The CP288 study is an investigation of a non-CE marked stoma product which was conducted in the UK, Italy, Netherlands, Germany, and Norway. The study enrolled 79 subjects. The study is a randomized, open-label, comparative study. The study is now complete.
The CP288 study is an investigation of a non-CE marked stoma product which will be conducted in the UK, Italy, Netherlands, Germany, and Norway. The study will enroll up to 100 subjects. The study is a randomized, open-label, comparative study.